Top Tweets for #Regdanvimab
The #SatoLab @SystemsVirology has the effect of 10 therapeutic monoc. #Antibodies against #BA275 evaluated (preprint):
#Adintrevimab
#bamlanivimab
#casirivimab
#etesevimab
#imdevimab didn't work
#Regdanvimab
#sotrovimab
#tixagevimab were functional against #Centaurus
The #Sato Lab @SystemsVirology hat die Wirkung von 10 therapeutischen monok. Antikörpern gegen #BA275 bewertet (Preprint):
#Adintrevimab
#bamlanivimab
#casirivimab
#etesevimab
#imdevimab wirkten nicht
#Regdanvimab
#sotrovimab
#tixagevimab waren gegen #Centaurus funktionsfähig
Según estudio (preprint) de Sato Lab, los anticuerpos monoclonales #sotrovimab, #tixagevimab y #regdanvimab pueden utilizarse contra BA.2.75 (Centaurus), aunque no contra BA.2 ni BA.4/5.
4⃣ #sotrovimab, #tixagevimab & #regdanvimab were not efficiently antiviral against BA.2 and BA.4/5. However, these 3 antibodies were functional against BA.2.75, suggesting that these 3 monoclonal antibodies can be used for anti-BA.2.75 therapy. 10/11
➡️ #sotrovimab , #tixagevimab y #regdanvimab
❌no fueron antivirales eficientes contra BA.2 y BA.4/5.
✅ Sin embargo, estos 3 anticuerpos fueron funcionales contra BA.2.75, lo que sugiere que estos 3 anticuerpos monoclonales se pueden usar para la terapia anti-BA.2.75.
Excellent data!
#Adintrevimab, #bamlanivimab, #casirivimab, #etesevimab, and #imdevimab did not work against BA.2.75
#Regdanvimab, #sotrovimab, and #tixagevimab were functional against BA.2.75
4⃣ 最後に、BA.2とBA.4/5は、#sotrovimab, #tixagevimab, #regdanvimab に抵抗性を示しました。一方、これらの抗体は、BA.2.75の感染を抑制しました。つまり、これら3つの抗体は、BA.2.75には有効であると考えられます。10/11
4⃣ #sotrovimab, #tixagevimab & #regdanvimab were not efficiently antiviral against BA.2 and BA.4/5. However, these 3 antibodies were functional against BA.2.75, suggesting that these 3 monoclonal antibodies can be used for anti-BA.2.75 therapy. 10/11
#Regdanvimab is associated with a significantly lower risk of disease aggravation without increasing adverse reactions in #COVID19 patients, a new study found.
👉https://t.co/7Za5kwwDCf
The Effectiveness of the Use of #Regdanvimab (CT-P59) in Addition to Remdesivir in #Patients with Severe #COVID19: A Single Center Retrospective #Study #openacces #mdpi
https://t.co/q2cGbPsD71
We are happy to announce that the TGA granted provisional approval to Celltrion Healthcare Australia Pty Ltd for the use of regdanvimab for the treatment of COVID-19.
Find out more at:
https://t.co/hmydq1XRjj
#CelltrionHealthcare #TGA #COVID19 #Regdanvimab #MonoclonalAntibodies
We are happy to announce that Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) won conditional approval from regulators in Peru (Dirección Nacional de Medicamentos, DIGEMID).
#CelltrionHealthcare #DIGEMID #COVID19 #Regdanvimab #CT_P59
The European Commission (EC) has approved our monoclonal antibody treatment #regdanvimab (CT-P59) for the treatment of #COVID-19 patients. We aim to accelerate global access to regdanvimab to help address the immediate needs.
#CelltrionHealthcare #MonoclonalAntibodies #EMA #EC
AB Komiyonu bugün bu iki ilacıda onaylamıştır. Bu ilaçlar #imdevimab +casirivimab ve #Regdanvimab ilaç tedavileridir. RKİ tarafından kullanılması önerilen ilaç tedavileri listesinede girmiştir. Hayırlı olsun.
https://t.co/Bj8oSMdlcw
Berlin: #Covid19 ile mücadelede yeni tedaviler ;
Avrupa İlaç Ajansı(EMA)Tıbbi Ürünler Komitesi (CHMP), COVID-19 için Roche/Regeneron'dan #Ronapreve (casirivimab/imdevimab) ve Celltrion'dan #Regkirona'nın (regdanvimab) onaylanmasını önerdi. AB Komiyonu onaylayacaktır.
We are excited to announce that #Celltrion received #CHMP positive opinion for #regdanvimab (CT-P59), as one of the first monoclonal antibodies recommended as a treatment for #COVID19 by the CHMP.
Read the full story here: https://t.co/kiVihduR4R
🦠 FLASH - Le régulateur européen a déclaré jeudi avoir approuvé pour la première fois la mise sur le marché dans l'UE de deux traitements par anticorps monoclonaux : le #Ronapreve et le #regdanvimab. (COVID-19)
(Le Progrès) #Traitement #Covid
🔴 INFO - #Europe : Le régulateur européen #EMA a approuvé la mise sur le marché dans l'Union européenne de deux traitements par anticorps contre le #coronavirus, le #Ronapreve du laboratoire suisse Roche, et le traitement de la société sud-coréenne #Celltrion, le #regdanvimab.
Berlin: #Regdanvimab, ek oksijen tedavisine ihtiyaç duymayan ancak ağır Covid-19'a yakalanma riski artan Covid-19'lu yetişkinleri tedavi etmek için kullanılmak üzere tasarlanmıştır.Bu ay sonu EMA onayı çıkması bekleniyor.Karar son güvenlik testlerinden sonra çıkacaktır.
(4/4)
⭐ EMA začala schvalovat monoklonální protilátku proti covidu #regdanvimab
⭐ byla by určena pacientům, kteří zatím nejsou připojeni na kyslík, ale je u nich velmi pravděpodobný těžký průběh onemocnění
⭐ EMA dál pokračuje v průběžném hodnocení 4 dalších léků na covid
La empresa presentó datos que respaldan que el #regdanvimab es efectivo para tratar a pacientes de #COVID19 adultos que no requieren oxígeno suplementario y que tienen un mayor riesgo de desarrollar síntomas graves de la enfermedad.
#DIRECTO | La #EMA estudia la autorización de 💊 #regdanvimab contra el 🦠 #Covid
➡️ https://t.co/YeiRMjaLy2
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.4M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.3M followers
Taylor Swift
@taylorswift13
81.2M followers
Lady Gaga
@ladygaga
72.7M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.4M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.7M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.1M followers
CNN
@cnn
61.9M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.4M followers